Compound ID | 1163
Class: Beta-lactam (cephalosporin, first generation)
| Spectrum of activity: | Gram-positive |
| Details of activity: | Active against Gram-positive bacteria |
| Description: | Buck, R.E et al "BL-S 217, a New Semi-synthetic Cephalosporin" Program and Abstracts of the interscience science Conference on Antimicrobial Agents and Chemotherapy. 1971. |
| Institute where first reported: | Bristol Myers Squibb |
| Year first mentioned: | 1971 |
| Highest development stage: | Preclinical |
| Development status: | Inactive |
| Reason dropped: | Resistance and competition from competing drugs |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/191168 |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC444167/ |